Endovascular Thrombectomy versus Intravenous Alteplase for Distal Vessel Occlusions: A Propensity Score-Matched Analysis
Yoshie, T.; the K-NET Registry Investigators, ; Ueda, T.; Hasegawa, Y.; Takeuchi, M.; Morimoto, M.; Tsuboi, Y.; Yamamoto, R.; Kaku, S.; Junichi, A.; Akiyama, T.; Yamamoto, D.; Mori, K.; Kagami, H.; Ito, H.; Onodera, H.; Kaga, Y.; Ohtsubo, H.; Tatsuno, K.; Usuki, N.; Takaishi, S.; Yamano, Y.
Show abstract
AbstractsO_ST_ABSBackgroundC_ST_ABSThe benefits of endovascular thrombectomy (EVT) for distal medium vessel occlusions (DMVOs) are not well established. This study aimed to evaluate whether EVT is superior to intravenous tissue plasminogen activator (IV tPA) alone in DMVOs. MethodsThis study analyzed data from the K-NET Registry, a prospective, multicenter, observational registry of acute ischemic stroke patients treated with EVT or IV tPA. The study evaluated patients with acute DMVOs who were treated with EVT and/or IV tPA. DMVOs was defined as occlusions in M2-M3 segment of the middle cerebral artery, anterior cerebral artery, or posterior cerebral artery. The analysis included primary DMVOs and excluded secondary DMVOs, such as distal embolism after recanalization of proximal vessel occlusion. Propensity score-matched analysis was conducted to compare the outcomes between EVT and IV tPA alone. A good outcome was defined as a modified Rankin Scale score of 0-2 or no worsening at 90 days. An excellent outcome was defined as an mRS score of 0-1. ResultsThe study included 1148 patients with DMVOs, of whom 816 were treated with EVT and 332 were IV tPA alone. Before propensity score matching, the incidence of good and excellent outcomes was significantly lower in EVT group (good outcomes: EVT 50.3% vs. IV tPA 68.0%, p<0.01; excellent outcomes: 39.8% vs. 59.8%, p<0.001). After propensity score matching, there were no significant differences between EVT and IV tPA groups in good outcomes (EVT 57.8% vs. IV tPA 61.3%, p=0.51), excellent outcomes (46.6% vs. 55.0%, p=0.17), all cerebral hemorrhage (11.6% vs. 12.7%, p=0.74), and symptomatic hemorrhage (2.9% vs. 0.6%, p=0.13). Subarachnoid hemorrhage was more frequent in EVT group (14.5% vs. IV tPA 0%). ConclusionsThe benefits of EVT for acute DMVOs were similar to IV-tPA alone. Randomized multicenter trials are warranted to establish the superiority of EVT over IV-tPA alone for DMVOs.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Safety Outcomes of Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions 98%
- Prospective Observational Cohort Study Of Tenecteplase Versus Alteplase In Routine Clinical Practice 97%
- Improvement in Delivery of Ischemic Stroke Treatments but Stagnation of Clinical Outcomes in Young Adults in South Korea 97%
Similar papers in this journal
- Adjunctive Intra-arterial Urokinase after Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Stroke (POST-UK): Study protocol of a multicenter, prospective, randomized, open-label, blinded-endpoint trial 98%
- Long term stability of patients undergoing endovascular parent artery occlusion of their intracranial artery 97%
- Computed tomography perfusion parameters predictive of symptomatic intracranial hemorrhage after mechanical thrombectomy in patients with cerebral large vessel occlusion 97%
Similar papers in this journal
- Predictors of survival in patients with ischemic stroke and active cancer: A prospective, multicenter, observational study 96%
- Intravenous Thrombolysis before Thrombectomy Improves Functional Outcome after Stroke Independent of Reperfusion Grade 96%
- Tenecteplase 0.4 mg/kg in moderate and severe acute ischemic stroke: A pooled analysis of NOR-TEST & NOR-TEST 2A 96%
Similar papers in this journal
- White matter lesions as a prognostic marker of recurrence in cryptogenic stroke with high-risk patent foramen ovale 98%
- Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Long-Term Day 90 Outcome 95%
- Impact of Fludrocortisone on the Outcomes of Subarachnoid Hemorrhage Patients: A Retrospective Analysis 95%
Similar papers in this journal
- Temporal Variations in Ischemic and Bleeding Event Risks after Acute Coronary Syndrome during Dual Antiplatelet Therapy 95%
- Two-Year Real World Clinical Outcomes after Intravascular Imaging Device Guided Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable-Polymer Sirolimus-Eluting Stent 94%
- Utility of the CHADS-P 2 A 2 RC score for estimating net adverse clinical events in chronic coronary syndrome patients without atrial fibrillation: insights from the CLIDAS-PCI 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.